ORAMED PHARMACEUTICALS INC. (ORMP) Insider Trading Disclosures
ORAMED PHARMACEUTICALS INC. (ORMP) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ORMP
CIK: 1176309
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Kesselman & Kesselman C.P.A.s
Auditor SinceSince 8/31/2017 12:00:00 AM
Lead Engagement PartnerBATIA RON
Audit LocationTel-Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-10-01 | 4 Filing | 0001213900-26-106531 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | 4 Filing | 0001213900-26-106530 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001976408-26-000877 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001976408-26-000876 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-24 | 4 Filing | 0001213900-26-103540 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-24 | 4 Filing | 0001213900-26-103538 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-24 | 4 Filing | 0001213900-26-103536 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-24 | 4 Filing | 0001213900-26-103535 | View SEC Doc Filr Page |
| 8-K | 2026-09-17 | 2026-09-15 | CURRENT REPORT | 0001213900-26-100929 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001493152-26-038125 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-087361 | View SEC Doc Filr Page |
| ARS | 2026-08-03 | 2025-12-31 | ARS | 0001213900-26-084613 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-03 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-084612 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-03 | 2026-09-15 | PROXY STATEMENT | 0001213900-26-084609 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-22 | — | SCHEDULE 13D/A Filing | 0001213900-26-080406 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | OWNERSHIP DOCUMENT | 0001213900-26-075070 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | OWNERSHIP DOCUMENT | 0001213900-26-075069 | View SEC Doc Filr Page |
| 144 | 2026-07-01 | — | 144 Filing | 0001976408-26-000609 | View SEC Doc Filr Page |
| 144 | 2026-07-01 | — | 144 Filing | 0001976408-26-000608 | View SEC Doc Filr Page |
| 8-K | 2026-06-30 | 2026-06-25 | CURRENT REPORT | 0001213900-26-073709 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-06-29 | — | SCHEDULE 13G/A Filing | 0001373604-26-000047 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-17 | — | SCHEDULE 13D/A Filing | 0001213900-26-069783 | View SEC Doc Filr Page |
| 10-Q | 2026-05-19 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-059112 | View SEC Doc Filr Page |
| NT 10-Q | 2026-05-15 | 2026-03-31 | NOTIFICATION OF LATE FILING | 0001213900-26-057722 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001493152-26-023496 | View SEC Doc Filr Page |